#RealWorldData
UM Greenebaum Comprehensive Cancer Center is now enrolling patients in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in patients not in a #ClinicalTrial. Learn more: bit.ly/pre1702-study
February 11, 2026 at 2:22 PM
Great work to ThedaCare for enrolling their first patient in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in patients not in a #ClinicalTrial. bit.ly/pre1702-study
February 10, 2026 at 2:56 PM
Kudos to Montefiore Medical Center for enrolling their first patient in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in patients not in a #ClinicalTrial. bit.ly/pre1702-study
February 9, 2026 at 8:00 PM
A groundbreaking FDA study reveals that many claims-data analyses can yield results strikingly similar to randomized trials, but with significant caveats.

Get the details!

#US #ClinicalTrials #CitizenPortal #RealWorldData #RegulatoryDecisions #USClaimsData
FDA study: many claims‑data real‑world analyses reach similar conclusions to randomized trials, with limits
An FDA‑funded demonstration that emulated randomized trials in U.S. claims data found many real‑world data (RWD) studies produced results similar to the original randomized controlled trials (RCTs)—a Pearson correlation of 0.82—while underscoring important limits related to data capture and emulation choices.
citizenportal.ai
February 9, 2026 at 4:11 AM
Ro and Amgen to examine barriers to #GLP-1 access in #obesity care using #RealWorldData | Becaris Publishing becarispublishing.com/digital-cont...
Becaris Publishing
becarispublishing.com
January 19, 2026 at 10:20 AM
GeneDx and Komodo Health partner to link #Genomic and #RealWorldData for #RareDisease evidence generation | Becaris Publishing becarispublishing.com/digital-cont...
Becaris Publishing
becarispublishing.com
January 14, 2026 at 12:38 PM
Kudos to Stanford Cancer Institute Palo Alto for enrolling their first patient in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in patients not in a #ClinicalTrial. bit.ly/pre1702-study
December 23, 2025 at 2:12 PM
Great work to Baptist Memorial Health Care for enrolling their first patient in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in patients not in a #ClinicalTrial. bit.ly/pre1702-study
December 17, 2025 at 2:49 PM
New Italian multicenter registry data reveal how pulmonary arterial hypertension (PAH) is diagnosed and treated in real life, early detection, comprehensive workups, and guideline-driven care. A sharper picture of patient needs.
#PAH #PulmonaryHypertension #RealWorldData #PHResearch #CardioScience'.
December 16, 2025 at 2:50 AM
Tufts Medical Center is now enrolling patients in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in patients not in a #ClinicalTrial. Learn more: bit.ly/pre1702-study
December 15, 2025 at 8:20 PM
Utilising real-world data to overcome challenges in rare disease research - buff.ly/YXAEiLm #clinicaltrial #clinicaltrials #raredisease #realworlddata
Utilising real-world data to overcome challenges in rare disease research
Synthetic control arms may help tackle the unique complexities, but key challenges such as data access and standardisation remain.
buff.ly
December 15, 2025 at 8:15 PM
📰 Read all about the results of Jesse Tettero’s research on the HARMONY Platform—just presented at #ASH25 —in this excellent article from @ascopost.bsky.social 👇

ascopost.com/news/decembe...

#hematology #Leukemia #AML #RealWorldData #DataSharing #RWE
New Pooled Analysis Strengthens Case for MRD as Surrogate Endpoint in AML
Measurable residual disease, regardless of method of assessment, is a robust individual-level predictor for overall survival among patients with acute myeloid leukemia who have already received induct...
ascopost.com
December 15, 2025 at 1:01 PM
Synapse: Your Connection to our MSK Authors.
Meet: Michael Forman Berger
Research Focus: Laboratory Medicine; Chief Attending

AI cancer driver mutation predictions are valid in real-world data

#AICancerResearch #CancerGenomics
#DriverMutations #RealWorldData #PrecisionOncology
#AIInMedicine
December 11, 2025 at 6:25 PM
Synapse: Your Connection to our MSK Authors.
Meet: Debyani Chakravarty
@CDebyaniPhD
Research Focus: AI cancer driver mutation predictions are valid in real-world data
synapse.mskcc.org/synapse/work...

#AIMutationPrediction #CancerGenomics #RealWorldData #AIDrivenOncology #PrecisionOncology
December 10, 2025 at 7:21 PM
Hey #statssky and #geronsky and #realworlddata lovers, if you're into data linkage and high quality data for #dementia research, and if you're an early stage investigator, have I got a mentoring program for you! See what the #NIA has posted and log on to the informational webinar next week!
The 1-year mentored training program builds skills and professional networks for postdocs, PhD students, and early-career investigators, interested in using real-world data to improve care of people living with #dementia. Info Webinar 12/08/2025, 1:00 PM ET!
#geronsky #statssky #realworlddata
Real World Data Scholars Program - NIA IMPACT Collaboratory
Program Overview The Real World Data Scholars Program is a 1-year mentored training experience designed to build practical skills and professional networks for early-career investigators, postdoctoral...
impactcollaboratory.org
December 3, 2025 at 4:44 PM
The 1-year mentored training program builds skills and professional networks for postdocs, PhD students, and early-career investigators, interested in using real-world data to improve care of people living with #dementia. Info Webinar 12/08/2025, 1:00 PM ET!
#geronsky #statssky #realworlddata
Real World Data Scholars Program - NIA IMPACT Collaboratory
Program Overview The Real World Data Scholars Program is a 1-year mentored training experience designed to build practical skills and professional networks for early-career investigators, postdoctoral...
impactcollaboratory.org
December 3, 2025 at 4:21 PM
Geisinger Cancer Institute is now enrolling patients in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in patients not in a #ClinicalTrial. Learn more: bit.ly/pre1702-study
December 3, 2025 at 2:21 PM
Real-world data, real-world impact. Transforming cancer research one connection at a time. 🌐

Read more: med.stanford.edu/cancer/about...

#RealWorldData #CancerCare #InnovationInScience
December 1, 2025 at 5:06 PM
📢 Real-world evidence
First-line pembrolizumab + chemo shows strong effectiveness and safety in advanced/recurrent ESCC:
✅ ORR: 60.9%
✅ Median OS: 17.3 months
Paclitaxel + platinum emerges as the best partner.
🔗 buff.ly/wb9uUJT
#ESCC #Immunotherapy #Oncology #RealWorldData
December 1, 2025 at 8:15 AM
The latest Evidence Insights feature, “Beyond Borders: The Evolving Role of Evidence Transportability” (in partnership with
@lumanity.bsky.social).

Read here >➡️ becarispublishing.com/spotlights/e...

#RWE #EvidenceTransportability #MarketAccess #RWD #RealWorldData #HealthTechnologyAssessment #HEOR
November 26, 2025 at 9:37 AM
Great work to Vanderbilt University Medical Center for enrolling their first patient in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in patients not in a #ClinicalTrial. bit.ly/pre1702-study
November 24, 2025 at 4:00 PM
@stanford-cancer.bsky.social is now enrolling patients in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in patients not in a #ClinicalTrial. Learn more: bit.ly/pre1702-study
November 24, 2025 at 3:54 PM
Attending #ASH25? Be sure to join me Sunday morning at the Hyatt at 9:30 am for our Special Interest Session “How Can Community-Based and Academic Hematologists Foster
Clinical Trial Participation as Part of Patient Care?” #blood #hematology #clinicaltrials #representation #realworlddata
November 22, 2025 at 6:45 PM